317 related articles for article (PubMed ID: 31701821)
21. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
[TBL] [Abstract][Full Text] [Related]
22. Stroke of antiplatelet and anticoagulant therapy in patients with coronary artery disease: a meta-analysis of randomized controlled trials.
Shao QY; Wang ZJ; Ma XT; Lin XZ; Pan L; Zhou YJ
BMC Cardiovasc Disord; 2021 Dec; 21(1):574. PubMed ID: 34852763
[TBL] [Abstract][Full Text] [Related]
23. Safety of percutaneous coronary intervention in patients with acute ischemic stroke/transient ischemic attack and acute coronary syndrome.
Zeus T; Ketterer U; Leuf D; Dannenberg L; Bönner F; Wagstaff R; Gliem M; Jander S; Kelm M; Polzin A
Clin Res Cardiol; 2016 Apr; 105(4):356-63. PubMed ID: 26514353
[TBL] [Abstract][Full Text] [Related]
24. Effects of Acute Coronary Syndrome and Stable Coronary Artery Disease on Bleeding and Ischemic Risk After Percutaneous Coronary Intervention.
Natsuaki M; Morimoto T; Shiomi H; Kadota K; Tada T; Takeji Y; Matsumura-Nakano Y; Yoshikawa Y; Watanabe H; Yamamoto K; Imada K; Domei T; Yamaji K; Kaneda K; Taniguchi R; Ehara N; Nawada R; Toyofuku M; Shinoda E; Suwa S; Tamura T; Inada T; Matsuda M; Aoyama T; Sato Y; Furukawa Y; Ando K; Nakagawa Y; Kimura T;
Circ J; 2021 Oct; 85(11):1928-1941. PubMed ID: 33907052
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Five-Year Outcome of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Triple-Vessel Coronary Artery Disease (from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2).
Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Tazaki J; Sakata R; Okabayashi H; Hanyu M; Shimamoto M; Nishiwaki N; Komiya T; Kimura T;
Am J Cardiol; 2015 Jul; 116(1):59-65. PubMed ID: 25956622
[TBL] [Abstract][Full Text] [Related]
26. Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stents.
Pilgrim T; Kalesan B; Zanchin T; Pulver C; Jung S; Mattle H; Carrel T; Moschovitis A; Stortecky S; Wenaweser P; Stefanini GG; Räber L; Meier B; Jüni P; Windecker S
EuroIntervention; 2013 Jan; 8(9):1061-71. PubMed ID: 23339812
[TBL] [Abstract][Full Text] [Related]
27. The prognostic value of bleeding academic research consortium (BARC)-defined bleeding complications in ST-segment elevation myocardial infarction: a comparison with the TIMI (Thrombolysis In Myocardial Infarction), GUSTO (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries), and ISTH (International Society on Thrombosis and Haemostasis) bleeding classifications.
Kikkert WJ; van Geloven N; van der Laan MH; Vis MM; Baan J; Koch KT; Peters RJ; de Winter RJ; Piek JJ; Tijssen JG; Henriques JP
J Am Coll Cardiol; 2014 May; 63(18):1866-75. PubMed ID: 24657697
[TBL] [Abstract][Full Text] [Related]
28. Impact of Cerebrovascular Events Older Than One Year on Ischemic and Bleeding Outcomes With Cangrelor in Percutaneous Coronary Intervention.
Sawlani NN; Harrington RA; Stone GW; Steg PG; Gibson CM; Hamm CW; Price MJ; Prats J; Deliargyris EN; Mahaffey KW; White HD; Bhatt DL
Circ Cardiovasc Interv; 2017 Jan; 10(1):. PubMed ID: 28039321
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of prior ischemic stroke in patients with coronary artery disease undergoing percutaneous coronary intervention.
Wang H; Ning X; Zhu C; Yin D; Feng L; Xu B; Guan C; Dou K
Catheter Cardiovasc Interv; 2019 Feb; 93(S1):787-792. PubMed ID: 30618111
[TBL] [Abstract][Full Text] [Related]
30. Ischemic and Bleeding Events Among Patients With Acute Coronary Syndrome Associated With Low-Dose Prasugrel vs Standard-Dose Clopidogrel Treatment.
Shoji S; Sawano M; Sandhu AT; Heidenreich PA; Shiraishi Y; Ikemura N; Ueno K; Suzuki M; Numasawa Y; Fukuda K; Kohsaka S
JAMA Netw Open; 2020 Apr; 3(4):e202004. PubMed ID: 32239221
[TBL] [Abstract][Full Text] [Related]
31. Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies.
Sorrentino S; Claessen BE; Chandiramani R; Guedeney P; Vogel B; Baber U; Rau V; Wang J; Krucoff M; Kozuma K; Ge J; Seth A; Makkar R; Liu Y; Bangalore S; Bhatt DL; Angiolillo DJ; Saito S; Neumann FJ; Hermiller J; Valgimigli M; Mehran R
Circulation; 2020 Mar; 141(11):891-901. PubMed ID: 31992063
[TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry.
Lindsey JB; Marso SP; Pencina M; Stolker JM; Kennedy KF; Rihal C; Barsness G; Piana RN; Goldberg SL; Cutlip DE; Kleiman NS; Cohen DJ;
JACC Cardiovasc Interv; 2009 Nov; 2(11):1074-82. PubMed ID: 19926047
[TBL] [Abstract][Full Text] [Related]
33. Influence of a history of cancer on long-term cardiovascular outcomes after coronary stent implantation (an Observation from Coronary Revascularization Demonstrating Outcome Study-Kyoto Registry Cohort-2).
Nakatsuma K; Shiomi H; Morimoto T; Watanabe H; Nakagawa Y; Furukawa Y; Kadota K; Ando K; Ono K; Shizuta S; Kimura T;
Eur Heart J Qual Care Clin Outcomes; 2018 Jul; 4(3):200-207. PubMed ID: 29897437
[TBL] [Abstract][Full Text] [Related]
34. Percutaneous Coronary Intervention Complexity and Risk of Adverse Events in relation to High Bleeding Risk among Patients Receiving Drug-Eluting Stents: Insights from a Large Single-Center Cohort Study.
Wang HY; Wang Y; Yin D; Gao RL; Yang YJ; Xu B; Dou KF
J Interv Cardiol; 2020; 2020():2985435. PubMed ID: 32405273
[TBL] [Abstract][Full Text] [Related]
35. Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease.
Ajufo E; Ayers CR; Vigen R; Joshi PH; Rohatgi A; de Lemos JA; Khera A
JAMA Cardiol; 2021 Feb; 6(2):179-187. PubMed ID: 33112372
[TBL] [Abstract][Full Text] [Related]
36. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP
J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574
[TBL] [Abstract][Full Text] [Related]
37. Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.
Yeh RW; Secemsky EA; Kereiakes DJ; Normand SL; Gershlick AH; Cohen DJ; Spertus JA; Steg PG; Cutlip DE; Rinaldi MJ; Camenzind E; Wijns W; Apruzzese PK; Song Y; Massaro JM; Mauri L;
JAMA; 2016 Apr; 315(16):1735-49. PubMed ID: 27022822
[TBL] [Abstract][Full Text] [Related]
38. Use of Chronic Oral Anticoagulation and Associated Outcomes Among Patients Undergoing Percutaneous Coronary Intervention.
Secemsky EA; Butala NM; Kartoun U; Mahmood S; Wasfy JH; Kennedy KF; Shaw SY; Yeh RW
J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792650
[TBL] [Abstract][Full Text] [Related]
39. Impact of Sex on 2-Year Clinical Outcomes in Patients Treated With 6-Month or 24-Month Dual-Antiplatelet Therapy Duration: A Pre-Specified Analysis From the PRODIGY Trial.
Gargiulo G; Ariotti S; Santucci A; Piccolo R; Baldo A; Franzone A; Magnani G; Marino M; Esposito G; Windecker S; Valgimigli M
JACC Cardiovasc Interv; 2016 Sep; 9(17):1780-9. PubMed ID: 27544007
[TBL] [Abstract][Full Text] [Related]
40. Bleeding Outcomes After Percutaneous Coronary Intervention in the Past Two Decades in Japan - From the CREDO-Kyoto Registry Cohort-2 and Cohort-3.
Natsuaki M; Morimoto T; Shiomi H; Yamamoto K; Yamaji K; Watanabe H; Uegaito T; Matsuda M; Tamura T; Taniguchi R; Inoko M; Mabuchi H; Takeda T; Domei T; Shirotani M; Ehara N; Eizawa H; Ishii K; Tanaka M; Inada T; Onodera T; Nawada R; Shinoda E; Yamada M; Yamamoto T; Sakai H; Toyofuku M; Tamura T; Takahashi M; Tada T; Sakamoto H; Tada T; Kaneda K; Miki S; Aoyama T; Suwa S; Sato Y; Ando K; Furukawa Y; Nakagawa Y; Kadota K; Kimura T;
Circ J; 2022 Apr; 86(5):748-759. PubMed ID: 34526432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
